Can needles quiet chronic pelvic pain?

NCT ID NCT05324280

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 20, 2026 · Last updated Aug 21, 2026 · Updated 1 time

Summary

This study asks whether adding acupuncture to a multidisciplinary treatment plan can reduce pain and improve quality of life for women with vulvodynia or chronic pelvic pain lasting at least six months. Half of the participants will receive acupuncture sessions, while the other half will be placed on a waiting list. Researchers will compare changes in pain scores and quality-of-life questionnaires between the two groups.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Acupuncture (body and ear acupuncture) as part of a multidisciplinary treatment
What this could lead to
If effective, acupuncture could become a standard part of multidisciplinary care to help women manage chronic pelvic pain and vulvodynia.
What could go wrong
This is a small, early-stage trial, and the waiting-list design may overestimate benefits. Acupuncture is generally safe but may cause minor bruising or discomfort.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

45 people

The number who actually took part.

Started

Jun 2022

Finished

Jul 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Women with vulvodynia and/or chronic pelvic pain of at least 6 months duration * multidisciplinary treatment for at least 3 months Exclusion Criteria: * Pregnancy * Current malignancy * Major neurologic or psychiatric morbidity * Study participation in Lydia trial (Lasertherapy for vulvodynia)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic pelvic pain are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Department of Gynecology/ Medical University of Graz

    Graz, 8036, Austria

More trials for these conditions

Other studies related to the condition(s) this trial covers.